Check out the companies making the biggest moves midday: Inspire Medical Systems , ResMed — Inspire Medical Systems and ResMed, which manufacture devices to treat obstructive sleep apnea, dropped 14% and 11%, respectively, following Friday's news that Eli Lilly 's weight loss drug tirzepatide reduced the severity of the condition. Eli Lilly also said it applied for approval from the Food and Drug Administration for the drug's treatment of sleep apnea.
The bank noted that Anheuser-Busch is "at the cusp of delivering the ideal consumer staples growth profile," citing an inflection point in growth, margins and cash returns. IBM — The stock spiked close to 3% after Goldman Sachs initiated coverage with a buy rating and a price target of $200, which implies 16% upside from Friday's close.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: CNBC - 🏆 12. / 72 続きを読む »